- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-10-0044831

Inaka Pharma Private Limited
About Inaka Pharma Private Limited
Data last updated:
Inaka Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 March 2022.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24303AP2022PTC121072. Its GSTIN is 37AAGCI5739K1Z2 (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sathish Kumar Attili and Talam Radha Krishna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 303 B – Block Aditya Fortune Towers Midhilapuri Vuda Colony Madhurawada, Visakhapatnam, Andhra Pradesh, India – 530041.
As per the financials filed for FY 2023, the company reported a revenue of ₹78.82 Lakh. For the same year it recorded a net profit of ₹20,523 (net margin 0.3%) and EBITDA of ₹1.67 Lakh (EBITDA margin 2.1%).
Inaka Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0044831).
Company details
Recognitions & Rankings of Inaka Pharma
Contact details
Inaka Pharma Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 303 B – Block Aditya Fortune Towers Midhilapuri Vuda Colony Madhurawada, Visakhapatnam, Andhra Pradesh, India – 530041
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Inaka Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Inaka Pharma Private Limited
FY 2025 filings availableInaka Pharma Private Limited reported revenue of ₹78.82 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹78.82 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1.67 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹20,523 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.1% | |
| Net Profit Margin | 0.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Inaka Pharma Private Limited, buy the company report.
Board of directors of Inaka Pharma Private Limited
Inaka Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sathish Kumar Attili Also directs: Stream Financial Services LLP | Director | 17 Mar 2022 | 4 Years 7 Months | Current |
| Talam Radha Krishna | Director | 17 Mar 2022 | 4 Years 7 Months | Current |
Auditor
Inaka Pharma Private Limited is audited by MURTHY & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MURTHY & ASSOCIATES | FY 2023 | 014085S |
Shareholding
The shareholding of Inaka Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Inaka Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inaka Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inaka Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Inaka Pharma Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
GST
Inaka Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAGCI5739K1Z2 | Andhra Pradesh | Active | 13 Apr 2022 |
To see the full GST registrations and return filing status of Inaka Pharma Private Limited, buy the company report.
Recent activity
Inaka Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Sathish Kumar Attili was appointed as Director on 17 Mar 2022.
Frequently asked questions
Inaka Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 March 2022 (4+ years old) and is registered under CIN U24303AP2022PTC121072.
Inaka Pharma has 2 current directors:
- Sathish Kumar Attili - Director
- Talam Radha Krishna - Director
The latest financial statements of Inaka Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Inaka Pharma is 37AAGCI5739K1Z2, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Inaka Pharma is U24303AP2022PTC121072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inaka Pharma was incorporated on 17 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Vijayawada.
Sathish Kumar Attili was appointed as Director on 17 Mar 2022. Talam Radha Krishna was appointed as Director on 17 Mar 2022.
Yes, Inaka Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-10-0044831).
The registered office of Inaka Pharma is at Flat No. 303 B – Block Aditya Fortune Towers Midhilapuri Vuda Colony Madhurawada, Visakhapatnam, Andhra Pradesh, India – 530041.
Inaka Pharma operates in the pharma industry, in the drug formulation and development segment.